Abigail Anne Risic

Array ( [id] => 112641 [patent_doc_number] => 07713932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Calcitonin drug-oligomer conjugates, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/166355 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17381 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713932.pdf [firstpage_image] =>[orig_patent_app_number] => 10166355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697254 [patent_doc_number] => 20030109448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells' [patent_app_type] => new [patent_app_number] => 10/289677 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7847 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109448.pdf [firstpage_image] =>[orig_patent_app_number] => 10289677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697262 [patent_doc_number] => 20030109456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'TRI-, TETRA-, and penta-peptides having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 10/283813 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11735 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109456.pdf [firstpage_image] =>[orig_patent_app_number] => 10283813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866855 [patent_doc_number] => 20080145914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Subcutaneous administration of coagulation Factor VII' [patent_app_type] => utility [patent_app_number] => 10/283751 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6735 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145914.pdf [firstpage_image] =>[orig_patent_app_number] => 10283751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835174 [patent_doc_number] => 20030162720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Therapeutic anti-HIV (IV9) compounds' [patent_app_type] => new [patent_app_number] => 10/283847 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19525 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162720.pdf [firstpage_image] =>[orig_patent_app_number] => 10283847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797453 [patent_doc_number] => 20030176327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Antibiotics for treating biohazardous bacterial agents' [patent_app_type] => new [patent_app_number] => 10/274692 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2945 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176327.pdf [firstpage_image] =>[orig_patent_app_number] => 10274692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 252798 [patent_doc_number] => 07579432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Cyclic peptides as G-protein-coupled receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/493117 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 19863 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579432.pdf [firstpage_image] =>[orig_patent_app_number] => 10493117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658297 [patent_doc_number] => 20030133927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Conjugates useful in the treatment of prostate cancer' [patent_app_type] => new [patent_app_number] => 10/268552 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18450 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20030133927.pdf [firstpage_image] =>[orig_patent_app_number] => 10268552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660137 [patent_doc_number] => 20030134781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Methods for the treatment of hyperpigmentation of skin' [patent_app_type] => new [patent_app_number] => 10/264392 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5922 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134781.pdf [firstpage_image] =>[orig_patent_app_number] => 10264392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005432 [patent_doc_number] => 06906028 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Stable insulin formulations' [patent_app_type] => utility [patent_app_number] => 10/264176 [patent_app_country] => US [patent_app_date] => 2002-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6902 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906028.pdf [firstpage_image] =>[orig_patent_app_number] => 10264176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602897 [patent_doc_number] => 20060293242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Transporting of taxoid derivatives through the blood brain barrier' [patent_app_type] => utility [patent_app_number] => 10/490357 [patent_app_country] => US [patent_app_date] => 2002-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3776 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293242.pdf [firstpage_image] =>[orig_patent_app_number] => 10490357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 758462 [patent_doc_number] => 07015307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-21 [patent_title] => 'Process for purifying glycopeptide phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 10/226676 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15111 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 436 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015307.pdf [firstpage_image] =>[orig_patent_app_number] => 10226676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847386 [patent_doc_number] => 20030166553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Compositions for preventing and treating digestive organs diseases' [patent_app_type] => new [patent_app_number] => 10/204555 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7192 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166553.pdf [firstpage_image] =>[orig_patent_app_number] => 10204555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 587930 [patent_doc_number] => 07439229 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Cytokine activity regulator molecules from tick salivary glands' [patent_app_type] => utility [patent_app_number] => 10/217342 [patent_app_country] => US [patent_app_date] => 2002-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10376 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439229.pdf [firstpage_image] =>[orig_patent_app_number] => 10217342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801783 [patent_doc_number] => 20030096948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Lipopeptide stereoisomers, methods for preparing same, and useful intermediates' [patent_app_type] => new [patent_app_number] => 10/213218 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13742 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096948.pdf [firstpage_image] =>[orig_patent_app_number] => 10213218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 236191 [patent_doc_number] => 07595172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-29 [patent_title] => 'Method for making acylated polypeptides' [patent_app_type] => utility [patent_app_number] => 10/205110 [patent_app_country] => US [patent_app_date] => 2002-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9234 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/595/07595172.pdf [firstpage_image] =>[orig_patent_app_number] => 10205110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707864 [patent_doc_number] => 07060681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids' [patent_app_type] => utility [patent_app_number] => 10/201547 [patent_app_country] => US [patent_app_date] => 2002-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 15631 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060681.pdf [firstpage_image] =>[orig_patent_app_number] => 10201547 [rel_patent_id] =>[rel_patent_doc_number] =>)